Pharmaceutical Regulatory Affairs: Open Access journal is a comparatively new profession which developed from the desire of governments to protect public health by controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines. The companies responsible for the discovery, testing, manufacture and marketing of these products also want to ensure that they supply products that are safe and make a worthwhile contribution to public health and welfare. OMICS Group International is one of the leading Open Access Publishers which is publishing 700+ peer-reviewed journals with the support of 50,000+ editorial board members as editorial team and aimed to disseminate the scholarly knowledge to the scientific society. OMICS Group also organizing 3000+ International Scientific Conferences and events yearly all over the world with the support of 1000+ Scientific associations worldwide. Pharmaceutical Regulatory Affairs: Open Access journals play a key role in the knowledge societies and this knowledge is rising by leaps and bounds within no time. Scientists and academicians require a broad understanding of the latest updates in the respective discipline for their professional and learning endeavors. OMICS International with its open access journals represents the research findings and advancements in various scientific and medical disciplines. Pharmaceutical Regulatory affairs is a journal dedicated to producing analysis, insight and data relating to questions of importance in understanding the pharmaceutical Regulatory affairs.
Last date updated on August, 2021